Gannet BioChem, a leading specialty chemical Contract Development and Manufacturing Organization (CDMO), today announced the ...

Since its initial public offering, ConvaTec has followed a familiar playbook to press its advantage in advanced wound care and to enhance its ostomy and continence care businesses. By and large ...

ConvaTec Group PLC CTEC shares rose 5.81% to £2.69 Wednesday, on what proved to be an all-around rough trading session for ...

In a report released today, Hassan Al-Wakeel from Barclays maintained a Buy rating on ConvaTec (CTEC – Research Report), with a price target of ...

RBC Capital analyst Jack Reynolds-Clark reiterated a Buy rating on ConvaTec (CTEC – Research Report) yesterday and set a price target of ...

ConvaTec Group PLC closed 13.75% short of its 52-week high of £2.95, which the company reached on April 4th.

ConvaTec Group has a fifty-two week low of GBX 211.80 ($2.74) and a fifty-two week high of GBX 295.20 ($3.82). The stock’s 50-day moving average is GBX 240.09 and its two-hundred day moving ...

Skin Barrier Products Market 2025 BURLINGAME, CA, UNITED STATES, March 11, 2025 /EINPresswire / --The Global Skin Barrier Products Mar ...

London’s FTSE 100 was up 0.6% at 8,720.80 in afternoon trade on Wednesday. Medical products company Convatec was the standout ...

London stocks were still in the black by midday on Wednesday, with Convatec pacing the gains after results, as investors eyed the latest earnings from US chip maker Nvidia.

Gannet BioChem has appointed several key executives following its recent acquisition by Ampersand Capital Partners.

The United Kingdom's stock market has recently experienced a downturn, with the FTSE 100 index closing lower due to weak trade data from China, highlighting concerns about global economic recovery. In ...